… Three immunocompromised patients with CMV disease resistant to ganciclovir were … of the
patients with retinitis had responses to intravenous ganciclovir therapy in a dose of 5 mg per …

… with ganciclovir; maintenance therapy does not appear to be … Ganciclovir is also useful
against cytomegalovirus infection in … or as early treatment for asymptomatic infection in bone …

… Ganciclovir prophylaxis for 4 weeks appears ineffective in heart … ganciclovir therapy has
shown greater efficacy in preventing CMV disease than sequential ganciclovir/aciclovir therapy …

… ganciclovir exerted an antiviral effect againstCMV and may playa role in the treatment of CMV
disease … is unusual in immunocompromised hosts in the absence of ganciclovir therapy.38 …

… Severe CMV infection may prove fatal. Therefore, we believe that early … of ganciclovir must
be considered in patients with CMV disease as soon as the severe nature of the infection is …

… standard anti-cytomegalovirus (CMV) drug ganciclovir. … ganciclovir for the treatment of
AIDS-related CMV retinitis, and oral ganciclovir for the prophylaxis of CMV infection and disease in …

… ganciclovir treatment range from below 2% up to almost 10%, with a higher incidence in CMV
… is noninferior to intravenous ganciclovir for eradication of CMV disease in SOT recipients (…

… Possible reasons for the suboptimal nature of early ganciclovir treatment in preventing early
CMV disease in this study are the exclusion of low grade antigenaemia as a trigger to start …

… prophylaxis in seropositive patients could reduce to near zero the 3% to 5% mortality rate
due to CMV disease seen in early treatment strategies. Our data suggest, however, that the …

… Models of pulmonary cytomegalovirus infection indicate that ganciclovir reduces viral titres …
suggest prophylactic ganciclovir may prevent cytomegalovirus infection. Ganciclovir was also …